507640124	507640124	CD	B-NP	O
|	|	NN	I-NP	O
VMC	VMC	NN	I-NP	O
|	|	NN	I-NP	O
01484143	01484143	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
891274	891274	CD	B-NP	O
|	|	CC	I-NP	O
1/13/1991	1/13/1991	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/13/1991	1/13/1991	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/20/1991	9/20/1991	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NN	I-NP	O
:	:	:	O	O
UNSTABLE	UNSTABLE	NN	B-NP	O
ANGINA	ANGINA	NN	I-NP	O
,	,	,	O	O
ADMITTED	ADMITTED	VBD	B-VP	O
FOR	FOR	NNP	B-NP	O
PERCUTANEOUS	PERCUTANEOUS	NNP	I-NP	O
TRANSLUMINAL	TRANSLUMINAL	NNP	I-NP	O
CORONARY	CORONARY	NNP	I-NP	O
ANGIOPLASTY	ANGIOPLASTY	NNP	I-NP	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

BILATERAL	BILATERAL	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
ARTERY	ARTERY	NNP	I-NP	O
STENOSIS	STENOSIS	NNP	I-NP	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
ONE	ONE	NN	I-NP	O
EPISODE	EPISODE	NN	I-NP	O
OF	OF	IN	B-PP	O
ATRIAL	ATRIAL	NN	B-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
ON	ON	NN	I-NP	O
13	13	CD	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
WITH	WITH	NNP	B-NP	O
SPONTANEOUS	SPONTANEOUS	NNP	I-NP	O
RESOLUTION	RESOLUTION	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
white	white	JJ	I-NP	O
male	male	JJ	I-NP	O
transferred	transfer	VBN	B-VP	O
from	from	IN	B-PP	O
Re	Re	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
after	after	IN	B-PP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
13	13	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
included	include	VBD	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1970	1970	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
basically	basically	RB	B-ADJP	O
pain-free	pain-free	JJ	I-ADJP	O
until	until	IN	B-PP	O
1985	1985	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
experiencing	experience	VBG	I-VP	O
stable	stable	JJ	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
equivalent	equivalent	NN	I-NP	O
is	be	VBZ	B-VP	O
bilateral	bilateral	JJ	B-NP	O
wrist	wrist	NN	I-NP	O
tingling	tingling	NN	I-NP	O
,	,	,	O	O
plus	plus	CC	B-PP	O
some	some	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
brought	bring	VBN	I-VP	O
on	on	RP	B-PRT	O
by	by	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
relieved	relieve	VBN	B-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
and	and	CC	I-NP	O
rest	rest	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
thallium	thallium	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
26	26	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
fatigue	fatigue	NN	B-NP	O
.	.	.	O	O

Maximal	Maximal	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
165/85	165/85	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
95	95	CD	I-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	O
pressure	pressure	NN	I-NP	O
product	product	NN	I-NP	O
15675	15675	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
his	his	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
wrist	wrist	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
his	his	PRP$	I-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
strain	strain	NN	B-NP	O
,	,	,	O	O
focal	focal	JJ	B-NP	O
premature	premature	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
contractions	contraction	NNS	I-NP	O
and	and	CC	O	O
ventricular	ventricular	JJ	B-NP	O
bigeminy	bigeminy	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
thallium	thallium	NN	I-NP	O
images	image	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
13	13	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
dull	dull	NN	I-NP	O
ache	ache	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
angina	angina	NN	I-NP	O
equivalent	equivalent	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
called	call	VBD	B-VP	O
his	his	PRP$	B-NP	B-DNA
Tlakeno	Tlakeno	NNP	I-NP	O
Rowt	Rowt	NNP	I-NP	O
.	.	.	O	O

Medical	Medical	NNP	B-NP	O
Center	Center	NNP	I-NP	O
Of	Of	IN	B-PP	O
physician	physician	NN	B-NP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
local	local	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
rate	rate	NN	I-NP	O
140	140	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
to	to	TO	B-PP	O
55	55	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
previous	previous	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
experienced	experience	VBD	B-VP	O
3	3	CD	B-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
equivalent	equivalent	NN	I-NP	O
of	of	IN	B-PP	O
wrist	wrist	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
relieved	relieve	VBN	B-VP	O
by	by	IN	B-PP	O
1	1	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
each	each	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
these	these	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
electrocardiogram	electrocardiogram	NN	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
intravenous	intravenous	JJ	B-NP	O
trinitroglycerin	trinitroglycerin	NN	I-NP	O
at	at	IN	B-PP	O
some	some	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
here	here	RB	B-ADVP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
rest	rest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
as	as	IN	B-PP	O
above	above	JJ	B-NP	O
,	,	,	I-NP	O
peptic	peptic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hiatal	hiatal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	VBP	B-VP	O
ADMISSION	ADMISSION	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
were	be	VBD	B-VP	O
diltiazem	diltiazem	JJ	B-ADJP	O
90	90	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
40	40	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
at	at	IN	B-PP	O
hour	hour	NN	B-NP	O
of	of	IN	B-PP	O
sleep	sleep	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
.25	.25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
included	include	VBD	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
desk	desk	NN	I-NP	O
job	job	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
furniture	furniture	NN	I-NP	O
store	store	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
used	use	VBD	B-VP	O
to	to	TO	I-VP	O
smoke	smoke	VB	I-VP	O
3	3	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
6	6	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
drinks	drink	VBZ	B-VP	O
3	3	CD	B-NP	O
beers	beer	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
son	son	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
other	other	JJ	I-NP	O
grown	grown	JJ	I-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NN	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
190/90	190/90	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
60	60	CD	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-NP	O
,	,	,	I-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
flat	flat	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
showed	show	VBD	B-VP	O
diminished	diminish	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
diffusely	diffusely	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
or	or	CC	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
III/VI	III/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
loudest	loud	JJS	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
II/VI	II/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
halfway	halfway	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Femoral	Femoral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	I-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
palpable	palpable	JJ	B-NP	O
pedal	pedal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
9	9	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
left	left	JJ	B-NP	O
atrium	atrium	NN	I-NP	O
size	size	NN	I-NP	O
42	42	CD	B-NP	O
millimeters	millimeter	NNS	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
posterior	posterior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
preserved	preserve	VBN	B-VP	O
systolic	systolic	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
sclerosis	sclerosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
mm/HG	mm/HG	NN	I-NP	O
,	,	,	O	O
read	read	VBN	B-VP	O
as	as	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
70	70	CD	B-NP	O
,	,	,	O	O
left	left	JJ	B-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
I	I	NN	B-NP	O
and	and	CC	I-NP	O
AVL	AVL	NN	I-NP	O
,	,	,	I-NP	O
V5	V5	NN	I-NP	B-protein
and	and	CC	I-NP	O
V6	V6	NN	I-NP	B-protein
,	,	,	O	O
strain	strain	NN	B-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

SMA-7	SMA-7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
urea	urea	NN	I-NP	O
nitrogen	nitrogen	NN	I-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
percutaneous	percutaneous	JJ	B-NP	O
transluminal	transluminal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
on	on	IN	B-PP	O
18	18	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
angina	angina	NN	B-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
changes	change	NNS	I-NP	O
anterolaterally	anterolaterally	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
percutaneous	percutaneous	JJ	B-NP	O
transluminal	transluminal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
on	on	IN	B-PP	O
18	18	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
obtuse	obtuse	NN	I-NP	B-DNA
marginal	marginal	JJ	I-NP	I-DNA
branch	branch	NN	I-NP	I-DNA
#	#	#	B-NP	I-DNA
2	2	CD	I-NP	I-DNA
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
distal	distal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
residual	residual	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
renal	renal	JJ	B-NP	O
angiography	angiography	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
arteriography	arteriography	NN	I-NP	O
and	and	CC	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
becuase	becuase	NN	B-NP	O
of	of	IN	B-PP	O
drug-resistant	drug-resistant	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	O	O
continued	continued	JJ	B-NP	O
hypokalemia	hypokalemia	NN	I-NP	O
requiring	require	VBG	B-VP	O
K	K	NN	B-NP	O
repletion	repletion	NN	I-NP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
off	off	RP	B-PRT	O
diuretics	diuretic	NNS	B-NP	O
.	.	.	O	O

Prior	Prior	JJ	B-NP	O
work-up	work-up	NN	I-NP	O
had	have	VBD	B-VP	O
revealed	reveal	VBN	I-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
hyperaldosteronism	hyperaldosteronism	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
was	be	VBD	B-VP	O
good	good	JJ	B-ADJP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
were	be	VBD	B-VP	O
Isordil	Isordil	NN	B-NP	O
30	30	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
at	at	IN	B-PP	O
hour	hour	NN	B-NP	O
of	of	IN	B-PP	O
sleep	sleep	NN	B-NP	O
,	,	,	O	O
Ecotrin	Ecotrin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
K-Dur	K-Dur	NNP	B-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nifedipine	Nifedipine	NN	B-NP	O
30	30	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
.25	.25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
time	time	NN	B-NP	O
his	his	PRP$	B-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

RE503/9695	RE503/9695	NNP	B-NP	O
MICHALE	MICHALE	NNP	I-NP	O
DEARSON	DEARSON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DC25	DC25	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/5/91	9/5/91	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
0102	0102	CD	B-NP	O
Report	Report	NNP	I-NP	O
:	:	:	O	O
E8453W6	E8453W6	NN	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/9/91	3/9/91	CD	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SHIRLEY	SHIRLEY	NNP	B-NP	O
HILTUNEN	HILTUNEN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
cc	cc	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

JESSE	JESSE	NN	B-NP	O
TOLZMANN	TOLZMANN	NN	I-NP	O
,	,	,	O	O
M.D	M.D	NN	B-NP	O
.	.	.	O	O

